1. Home
  2. LSTA vs NCL Comparison

LSTA vs NCL Comparison

Compare LSTA & NCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • NCL
  • Stock Information
  • Founded
  • LSTA 1980
  • NCL 2013
  • Country
  • LSTA United States
  • NCL United States
  • Employees
  • LSTA N/A
  • NCL N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • NCL
  • Sector
  • LSTA Health Care
  • NCL
  • Exchange
  • LSTA Nasdaq
  • NCL Nasdaq
  • Market Cap
  • LSTA 20.0M
  • NCL 21.7M
  • IPO Year
  • LSTA N/A
  • NCL 2023
  • Fundamental
  • Price
  • LSTA $2.18
  • NCL $0.64
  • Analyst Decision
  • LSTA Strong Buy
  • NCL
  • Analyst Count
  • LSTA 1
  • NCL 0
  • Target Price
  • LSTA $15.00
  • NCL N/A
  • AVG Volume (30 Days)
  • LSTA 10.9K
  • NCL 8.1M
  • Earning Date
  • LSTA 05-08-2025
  • NCL 05-20-2025
  • Dividend Yield
  • LSTA N/A
  • NCL N/A
  • EPS Growth
  • LSTA N/A
  • NCL N/A
  • EPS
  • LSTA N/A
  • NCL N/A
  • Revenue
  • LSTA $1,000,000.00
  • NCL $15,576,857.00
  • Revenue This Year
  • LSTA N/A
  • NCL N/A
  • Revenue Next Year
  • LSTA N/A
  • NCL N/A
  • P/E Ratio
  • LSTA N/A
  • NCL N/A
  • Revenue Growth
  • LSTA N/A
  • NCL 47.13
  • 52 Week Low
  • LSTA $1.87
  • NCL $0.15
  • 52 Week High
  • LSTA $4.20
  • NCL $0.69
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 44.79
  • NCL 86.84
  • Support Level
  • LSTA $2.07
  • NCL $0.41
  • Resistance Level
  • LSTA $2.46
  • NCL $0.77
  • Average True Range (ATR)
  • LSTA 0.17
  • NCL 0.08
  • MACD
  • LSTA -0.02
  • NCL 0.02
  • Stochastic Oscillator
  • LSTA 22.92
  • NCL 74.49

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About NCL Northann Corp.

Northann Corp specialized in 3D-printed flooring solutions under its flagship brand, "Benchwick." The company's operations span the full spectrum of additive manufacturing, from sourcing recycled ocean plastics to the final production of intricate flooring designs. Northann offers an extensive range of proprietary solutions, including Infinite Glass, DSE, TruBevel, and MattMaster, primarily through its sales network in North America and Europe.

Share on Social Networks: